FIELD: medicine, dermatovenerology. SUBSTANCE: method involves the preliminary assay of antibodies in blood to cytoplasmatic antigen and at value below 2.84 ± 0.21 ln1/titer the native staphyloprotectin is administrated subcutaneously at dose 0.2-0.3-0.5-0.8 ml at 3 days interval and then after 2 months adsorbed staphyloprotectin is administrated as a single dose 0.8 ml. EFFECT: improved method of treatment. 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF DIAGNOSIS OF STAPHYLOCOCCUS INFECTION | 1998 |
|
RU2144190C1 |
| METHOD OF TREATMENT OF PATIENTS WITH TRUE ECZEMA | 1996 |
|
RU2140791C1 |
| METHOD OF PREPARING PURIFIED LIQUID STAPHYLOCOCCUS ANATOXIN FOR SPECIFIC IMMUNOTHERAPY OF PATIENTS WITH STAPHYLOCOCCUS INFECTION | 2000 |
|
RU2169580C1 |
| METHOD OF TREATING BABIES SUFFERING INTESTINAL COLICS | 2010 |
|
RU2425679C1 |
| METHOD OF TREATING PATIENTS ILL WITH TORPID PSORIASIS | 0 |
|
SU1022713A1 |
| METHOD OF PROPHYLAXIS OF DIPHTHERIA | 1996 |
|
RU2135174C1 |
| IMMUNE CORRECTION METHOD FOR TREATING LINGERING FORMS OF HEPATITIS | 0 |
|
SU1678373A1 |
| METHOD FOR TREATMENT OF ATOPIC DERMATITIS | 2003 |
|
RU2235556C1 |
| 0 |
|
SU304952A1 | |
| METHOD OF PATIENTS' PREVENTIVE VACCINATION | 2006 |
|
RU2348402C2 |
